Arch Therapeutics, Inc. to Present at the New York City based Investor Summit on March 25th-26th

Author's Avatar
Mar 18, 2020
Article's Main Image

NEW YORK, NY / ACCESSWIRE / March 18, 2020 / Arch Therapeutics, Inc. (OTCQB:ARTH), developer of novel liquid, gel and solid hemostatic and wound care devices, is scheduled to provide a corporate update at this year's New York City based Investor Summit on March 25th-26th.